Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (11-20 of 662) with videos related to

Pageof 67
Sort By:
Biologics : Targets & Therapy|August 27, 2009
Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approachesPeter Valent
Blood|February 18, 2009
Interleukin-33: a regulator of basophilsPeter Valent
European Journal of Clinical Investigation|July 6, 2010
Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor?Peter Valent
Hematology. American Society of Hematology. Education Program|December 13, 2012
Low blood counts: immune mediated, idiopathic, or myelodysplasiaPeter Valent
Expert Review of Hematology|November 19, 2010
Classification and response criteria in mastocytosis: is there a need to revise?Peter Valent
Wiener Klinische Wochenschrift|June 9, 2005
Mast cells, masters, and mastocytosis: development of research since the times of Paul EhrlichPeter Valent
Immunology and Allergy Clinics of North America|August 26, 2006
Diagnostic evaluation and classification of mastocytosisPeter Valent
American Journal of Cancer Research|April 18, 2013
Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathologyPeter Valent
Cancer Treatment and Research|February 21, 2008
Systemic mastocytosisPeter Valent
Leukemia Research|April 18, 2008
Low erythropoietin production as non-oncogenic co-factor contributing to disease-manifestation in low-risk MDS: a hypothesis supported by unique case reportsPeter Valent
Pageof 67

Showing results (11-20 of 662) with videos related to

Sort By:
Pageof 67
Biologics : Targets & Therapy|August 27, 2009
Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approachesPeter Valent
Blood|February 18, 2009
Interleukin-33: a regulator of basophilsPeter Valent
European Journal of Clinical Investigation|July 6, 2010
Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor?Peter Valent
Hematology. American Society of Hematology. Education Program|December 13, 2012
Low blood counts: immune mediated, idiopathic, or myelodysplasiaPeter Valent
Expert Review of Hematology|November 19, 2010
Classification and response criteria in mastocytosis: is there a need to revise?Peter Valent
Wiener Klinische Wochenschrift|June 9, 2005
Mast cells, masters, and mastocytosis: development of research since the times of Paul EhrlichPeter Valent
Immunology and Allergy Clinics of North America|August 26, 2006
Diagnostic evaluation and classification of mastocytosisPeter Valent
American Journal of Cancer Research|April 18, 2013
Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathologyPeter Valent
Cancer Treatment and Research|February 21, 2008
Systemic mastocytosisPeter Valent
Leukemia Research|April 18, 2008
Low erythropoietin production as non-oncogenic co-factor contributing to disease-manifestation in low-risk MDS: a hypothesis supported by unique case reportsPeter Valent
Pageof 67